Clinical trial
Early Diagnosis and Treatment of Infections in Patients With Haematologic Malignancies: Examining Novel Diagnostics Including Bacterial and Fungal Multiplex PCR and FDG-PET Imaging
NCT03429387 is registered in ClinicalTrials.gov with Peter MacCallum Cancer Centre, Australia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Diagnosis and Treatment of Infections in Patients With Haematologic Malignancies: Examining Novel Diagnostics Including Bacterial and Fungal Multiplex PCR and FDG-PET Imaging
- Lead sponsor
- Peter MacCallum Cancer Centre, Australia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 8, 2018
- Completion date
- January 23, 2021
- Enrollment
- 147 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, acute myeloid leukemia, febrile neutropenia, haematopoietic stem cell transplant, allogeneic, haematopoietic stem cell transplant, autologous